The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma
HPB · 2023
DOI: 10.1016/j.hpb.2023.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2023. Verfasst von Jenny H Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, Digestive Disease and Surgery Institute, Department of General Surgery, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Robotic Surgical Procedures, Laparoscopy. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In distal pancreatectomy (DP) for pancreatic ductal adenocarcinoma (PDAC), we hypothesize that minimally invasive DP (MIDP) carries short-term benefits over ODP (ODP) in the absence of postoperative pancreatic fistula (POPF). METHODS: NSQIP database was queried to select patients who underwent DP for PDAC with available report on POPF. The population was divided into No-POPF vs. POPF groups. In each group, propensity-score matching was applied to compare 30-day outcomes of ODP vs. MIDP. RESULTS: There were 2,824 patients; 2,332 (82%) had No-POPF and 492 (21%) had POPF. In No-POPF patients, 921 pairs were matched between ODP and MIDP. MIDP patients had slightly longer operations (227 vs. 205 minutes; p < 0.001), but lower rates of surgical site complications (1% vs. 2.9%; p = 0.002), postoperative transfusion (7.1% vs. 11.0%; p = 0.003), overall morbidity (21.1% vs. 26.3%; p = 0.009), and one-day shorter median length of stay (LOS) (5 vs. 6 days; p = 0.001). In the POPF group, 172 pairs were matched. There was no difference in morbidity, mortality, reoperation, LOS, and home discharge. Similar conclusions were drawn in the intention-to-treat and per-protocol analyses. CONCLUSION: POPF is common following DP for PDAC. In the absence of POPF, MIDP is associated with fewer postoperative morbidities and shorter LOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cleveland Clinic, Digestive Disease and Surgery Institute, Department of General Surgery, Cleveland, OH, USA.
- Edward-Elmhurst Medical Group, Department of Surgical Oncology, Naperville, IL, USA.
- H. Lee Moffitt Cancer Center & Research Institute, Department of Gastrointestinal Oncology, Tampa, FL, USA.
- Cleveland Clinic, Digestive Disease and Surgery Institute, Department of General Surgery, Cleveland, OH, USA. Electronic address: naffous@ccf.org.
Zitieren
APA
Chang, J. H., Hossain, M. S., Stackhouse, K., Dahdaleh, F., Denbo, J., Augustin, T., Simon, R., Joyce, D., Matthew Walsh, R., & Naffouje, S. (2023). The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma. HPB. https://doi.org/10.1016/j.hpb.2023.06.003
Vancouver
Chang JH, Hossain MS, Stackhouse K, Dahdaleh F, Denbo J, Augustin T, et al. The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma. HPB. 2023. doi:10.1016/j.hpb.2023.06.003
BibTeX
@article{Chang2023,
author = {Chang, Jenny H and Hossain, Mir S and Stackhouse, Kathryn and Dahdaleh, Fadi and Denbo, Jason and Augustin, Toms and Simon, Robert and Joyce, Daniel and Matthew Walsh, R and Naffouje, Samer},
title = {The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma},
journal = {HPB},
year = {2023},
doi = {10.1016/j.hpb.2023.06.003}
}
EUVIMED